Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nimanthi Jayathilaka

Reversal of Pathological Cardiac Hypertrophy via the MEF2-coregulator Interface

JCI insight
Medicine
2017English

Differential Expression of microRNA, miR-150 and Enhancer of Zeste Homolog 2 (EZH2) in Peripheral Blood Cells as Early Prognostic Markers of Severe Forms of Dengue

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2020English

Related publications

Tripartite Motif 32 Prevents Pathological Cardiac Hypertrophy

Clinical Science
Medicine
2016English

Nuclear GAPDH Signaling Mediates Pathological Cardiac Hypertrophy

2019English

The Transcription Factor GATA-6 Regulates Pathological Cardiac Hypertrophy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

CaM Kinase Signaling Induces Cardiac Hypertrophy and Activates the MEF2 Transcription Factor in Vivo

Journal of Clinical Investigation
Medicine
2000English

The H3K9 Dimethyltransferases EHMT1/2 Protect Against Pathological Cardiac Hypertrophy

Journal of Clinical Investigation
Medicine
2016English

Mechanisms for the Transition From Physiological to Pathological Cardiac Hypertrophy

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2020English

Fibronectin Contributes to Pathological Cardiac Hypertrophy but Not Physiological Growth

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy

Hypertension
Internal Medicine
2013English

Tom70 Serves as a Molecular Switch to Determine Pathological Cardiac Hypertrophy

Cell Research
Cell BiologyMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy